Lysosomal enzymes and pancreatitis during rifampicin therapy.
D000118:Acetylglucosaminidase / Q000096:biosynthesis*; D000208:Acute Disease; D004790:Enzyme Induction; D005966:Glucuronidase / Q000096:biosynthesis*; D006596:Hexosaminidases / Q000096:biosynthesis*; D006801:Humans; D008099:Liver / Q000187:drug effects* / Q000473:pathology; D008247:Lysosomes / Q000201:enzymology*; D010195:Pancreatitis / Q000139:chemically induced*; D012293:Rifampin / Q000494:pharmacology* / Q000627:therapeutic use; D013307:Streptomycin / Q000494:pharmacology / Q000627:therapeutic use
D006596:Hexosaminidases; D005966:Glucuronidase; D000118:Acetylglucosaminidase; D012293:Rifampin; D013307:Streptomycin